NCT07158151

A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of RSS0393 Ointment in Adults With Mild to Moderate Atopic Dermatitis

• Status: Active Not Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 168 (actual)
• Sponsor: Reistone Biopharma Company Limited · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is ongoing to explore the efficacy and safety of different strengths of RSS0393 ointment in adults with atopic dermatitis

Conditions

• Atopic Dermatitis of Adults

Interventions

Type	Name	Description
DRUG	RSS0393 ointment	RSS0393 ointment 0.05%
DRUG	RSS0393 ointment	RSS0393 ointment 0.01%
DRUG	RSS0393 ointment	RSS0393 ointment 0.03%
DRUG	RSS0393 ointment	RSS0393 ointment placebo

Timeline

• Start date: 2025-09-25
• Primary completion: 2026-03-01
• Completion: 2026-05-01
• First posted: 2025-09-05
• Last updated: 2026-01-29

Locations

1 site across 1 country: China